Dow Down 0.52% Nasdaq Up 0.34%

Alkermes plc (ALKS)

-NasdaqGS
43.64 Up 0.56(1.30%) 10:10AM EDT - Nasdaq Real Time Price
Prev Close:43.08
Open:42.88
Bid:43.28 x 300
Ask:43.37 x 200
1y Target Est:50.92
Beta:1.71
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:42.88 - 43.80
52wk Range:34.21 - 54.25
Volume:85,243
Avg Vol (3m):853,582
Market Cap:6.36B
P/E (ttm):N/A
EPS (ttm):-0.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALKS

Comparison

Symbol% ChgMkt Cap
ALKSUp 1.30%6.36B
ABTUp 0.15%61.53B
LLYDown 0.10%67.00B
GSKDown 0.62%104.25B

Key Statistics

Forward P/E (1 yr):73.37
P/S (ttm):11.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.27
Quarterly EPS Est (Sep-14) :0.02
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):5.54

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback